Time Course of Humoral and Cell-Mediated Immune Responses to Human Papillomavirus Type 16 in Infected Women
- 1 July 2002
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (4) , 877-882
- https://doi.org/10.1128/cdli.9.4.877-882.2002
Abstract
The time course of cell-mediated and humoral immune responses was elucidated in eight women with human papillomavirus type 16 (HPV-16) infection by performing serial HPV-16 E6 and E7 cytotoxic T-lymphocyte (CTL) assays and HPV-16 virus-like particle (VLP) antibody analyses. Four subjects had a single incident of HPV-16 DNA detection, and four subjects had two periods of HPV-16 DNA detection. In two of the women in the latter group, the second episode of HPV-16 detection occurred in the presence of high titers of HPV-16 VLP antibody, bringing into question the protective role of humoral immunity in preventing repeated infection. However, all four subjects rapidly became HPV-16 DNA negative following the second detection of HPV-16 DNA, suggesting the presence of immunological memory. In addition, one subject rapidly became negative for HPV-16 DNA despite having no evidence of CTL or VLP antibody response prior to the second HPV-16 DNA detection, suggesting the presence of immunological responses at an undetectable level. Overall, seven of eight subjects (88%) had detectable HPV-16 E6 and/or E7 CTL responses and seven of eight women (88%) had detectable HPV-16 VLP antibody responses.Keywords
This publication has 53 references indexed in Scilit:
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Seroreactivity to Human Papillomavirus Types 16, 18, 31, and 45 Virus‐Like Particles in a Case‐Control Study of Cervical Squamous Intraepithelial LesionsThe Journal of Infectious Diseases, 1999
- T Cell Proliferative Responses Against Human Papillomavirus Type 16 E7 Oncoprotein are Most Prominent in Cervical Intraepithelial Neoplasia Patients with a Persistent Viral InfectionJournal of General Virology, 1996
- Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasiaJournal of General Virology, 1996
- Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma.Journal of Clinical Pathology, 1995
- Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specificJournal of General Virology, 1994
- Serologic response in human papillomavirus‐associated invasive cervical cancerInternational Journal of Cancer, 1993
- Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNAInternational Journal of Cancer, 1993
- Identification of Antibodies against Human Papillomavirus Type 16 E6 and E7 Proteins in Sera of Patients with Cervical NeoplasiasJapanese Journal of Cancer Research, 1992
- Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasiaEpidemiology and Infection, 1989